{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:40:57Z","timestamp":1793018457311,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jpainsymman.2023.06.033","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T11:14:53Z","timestamp":1688814893000},"page":"e687-e692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Should Urine Drug Screen be Done Universally or Selectively in Palliative Care Patients on Opioids?"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9185-6108","authenticated-orcid":false,"given":"Joseph","family":"Arthur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6876-7660","authenticated-orcid":false,"given":"Julie","family":"Childers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egidio","family":"Del Fabbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0001","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/1049909114531445","article-title":"Chronic pain and risk factors for opioid misuse in a palliative care clinic","volume":"32","author":"Childers","year":"2015","journal-title":"Am J Hosp Palliat Care"},{"issue":"6","key":"10.1016\/j.jpainsymman.2023.06.033_bib0002","first-page":"1859","article-title":"Urine drug screen findings among ambulatory oncology patients in a supportive care clinic","volume":"25","author":"Rauenzahn","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0003","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/pm\/pnx178","article-title":"Compliance with opioid therapy: distinguishing clinical characteristics and demographics among patients with cancer pain","volume":"19","author":"Koyyalagunta","year":"2018","journal-title":"Pain Med"},{"issue":"4","key":"10.1016\/j.jpainsymman.2023.06.033_bib0004","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/jamaoncol.2019.6756","article-title":"Random vs targeted urine drug testing among patients undergoing long-term opioid treatment for cancer pain","volume":"6","author":"Arthur","year":"2020","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.jpainsymman.2023.06.033_bib0005","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/cncr.33326","article-title":"Random urine drug testing among patients receiving opioid therapy for cancer pain","volume":"127","author":"Arthur","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0006","unstructured":"Network NCC. NCCN clinical practice guidelines in oncology: adult cancer pain (version 1.2018). Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pain.pdf. Published 2018. Accessed May 9, 2018."},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0007","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jpainsymman.2020.11.033","article-title":"Identifying prevalence of and risk factors for abnormal urine drug tests in cancer pain patients","volume":"62","author":"Leap","year":"2021","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.jpainsymman.2023.06.033_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"2S","key":"10.1016\/j.jpainsymman.2023.06.033_bib0009","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.36076\/ppj.2017.s92","article-title":"Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: american society of interventional pain physicians (ASIPP) guidelines","volume":"20","author":"Manchikanti","year":"2017","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0010","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1526-4637.2012.01414.x","article-title":"Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain","volume":"13","author":"Peppin","year":"2012","journal-title":"Pain Med"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0011","series-title":"Interagency guideline on prescribing opioids for pain","year":"2015"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/pm\/pnx285","article-title":"Rational urine drug monitoring in patients receiving opioids for chronic pain: consensus recommendations","volume":"19","author":"Argoff","year":"2018","journal-title":"Pain Med"},{"issue":"3 Suppl","key":"10.1016\/j.jpainsymman.2023.06.033_bib0013","first-page":"ES119","article-title":"Urine drug testing: current recommendations and best practices","volume":"15","author":"Owen","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0014","doi-asserted-by":"crossref","first-page":"123","DOI":"10.36076\/ppj.2011\/14\/123","article-title":"Urine drug testing in chronic pain","volume":"14","author":"Christo","year":"2011","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0015","unstructured":"Prevention TCfDCa. Clinical quality improvement opioid measures. Available at: https:\/\/www.cdc.gov\/opioids\/healthcare-admins\/pdf\/Clinical-Quality-Improvement-Opioid-Measures-508.pdf. Accessed February 21, 2023."},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0016","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1002\/cncr.34392","article-title":"Interdisciplinary intervention for the management of nonmedical opioid use among patients with cancer pain","volume":"128","author":"Arthur","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0017","first-page":"33","article-title":"Urine drug tests: ordering and interpreting results","volume":"99","author":"Kale","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0018","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7326\/0003-4819-152-11-201006010-00004","article-title":"Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain","volume":"152","author":"Starrels","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0019","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2013United States","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0020","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.2018.9739","article-title":"Use of palliative care earlier in the disease course in the context of the opioid epidemic: educational, research, and policy issues","volume":"320","author":"Schenker","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0021","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1089\/jpm.2015.0098","article-title":"Do palliative care clinics screen for substance abuse and diversion? Results of a national survey","volume":"18","author":"Tan","year":"2015","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2023.0441","article-title":"Association of race with urine toxicology testing among pregnant patients during labor and delivery","volume":"4","author":"Jarlenski","year":"2023","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.100913","article-title":"Reduction of racial disparities in urine drug testing after implementation of a standardized testing policy for pregnant patients","volume":"5","author":"Peterson","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0024","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11916-020-00918-z","article-title":"Review of the current state of urine drug testing in chronic pain: still effective as a clinical tool and curbing abuse, or an arcane test?","volume":"25","author":"Chakravarthy","year":"2021","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11606-019-05514-5","article-title":"Provider misinterpretation, documentation, and follow-up of definitive urine drug testing results","volume":"35","author":"Chua","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0026","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1200\/JCO.21.00476","article-title":"US trends in opioid access among patients with poor prognosis cancer near the end-of-life","volume":"39","author":"Enzinger","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0027","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/jpm.2018.0168","article-title":"Opioid screening practices in the cancer pain patient","volume":"22","author":"Liebling","year":"2019","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.39968","article-title":"Expert panel consensus on management of advanced cancer-related pain in individuals with opioid use disorder","volume":"4","author":"Merlin","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpainsymman.2023.06.033_bib0029","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1634\/theoncologist.2019-0525","article-title":"Urine drug testing in cancer pain management","volume":"25","author":"Arthur","year":"2020","journal-title":"Oncologist"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392423005808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392423005808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:38:57Z","timestamp":1760132337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392423005808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0885392423005808"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2023.06.033","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should Urine Drug Screen be Done Universally or Selectively in Palliative Care Patients on Opioids?","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2023.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}